Thornburg Investment Management’s Novartis NVS Stock Holding History

Thornburg Investment Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$628K	Sell	4,114 -775	-16%	-$119K	0.01%	150
2025 Q4	$674K	Hold	4,889	–	–	0.01%	163
2025 Q3	$627K	Hold	4,889	–	–	0.01%	162
2025 Q2	$592K	Hold	4,889	–	–	0.01%	162
2025 Q1	$5.45M	Sell	4,889 -2,911	-37%	-$310K	0.01%	175
2024 Q4	$759K	Hold	7,800	–	–	0.01%	179
2024 Q3	$897K	Hold	7,800	–	–	0.01%	180
2024 Q2	$830K	Hold	7,800	–	–	0.01%	176
2024 Q1	$754K	Buy	7,800 +966	+14%	+$99K	0.01%	178
2023 Q4	$690K	Sell	6,834 -578	-8%	-$55.8K	0.01%	185
2023 Q3	$755K	Hold	7,412	–	–	0.01%	180
2023 Q2	$748K	Hold	7,412	–	–	0.01%	174
2023 Q1	$682K	Buy	7,412 +1,240	+20%	+$108K	0.01%	173
2022 Q4	$560K	Hold	6,172	–	–	0.01%	187
2022 Q3	$469K	Hold	6,172	–	–	0.01%	192
2022 Q2	$522K	Sell	6,172 -550	-8%	-$48.3K	0.01%	191
2022 Q1	$590K	Sell	6,722 -3,873	-37%	-$335K	0.01%	187
2021 Q4	$927K	Buy	10,595 +1,225	+13%	+$102K	0.01%	186
2021 Q3	$766K	Hold	9,370	–	–	0.01%	191
2021 Q2	$855K	Hold	9,370	–	–	0.01%	191
2021 Q1	$801K	Hold	9,370	–	–	0.01%	177
2020 Q4	$885K	Hold	9,370	–	–	0.01%	179
2020 Q3	$815K	Hold	9,370	–	–	0.01%	133
2020 Q2	$818K	Hold	9,370	–	–	0.01%	131
2020 Q1	$773K	Buy	+9,370	New	+$836K	0.01%	135
2019 Q3	–	Sell	-171,638	Closed	-$15.7M	–	176
2019 Q2	$15.7M	Sell	171,638 -149,306	-47%	-$12.6M	0.15%	98
2019 Q1	$27.6M	Sell	320,944 -75,223	-19%	-$6.04M	0.27%	81
2018 Q4	$30.5M	Buy	396,167 +5,431	+1%	+$423K	0.3%	71
2018 Q3	$30.2M	Sell	390,736 -12	-0%	-$887	0.25%	79
2018 Q2	$26.4M	Buy	390,748 +74,783	+24%	+$5.16M	0.2%	98
2018 Q1	$22.9M	Buy	315,965 +15,356	+5%	+$1.17M	0.17%	116
2017 Q4	$22.6M	Buy	300,609 +6,326	+2%	+$477K	0.16%	118
2017 Q3	$22.6M	Buy	294,283 +49,157	+20%	+$3.71M	0.16%	119
2017 Q2	$18.3M	Sell	245,126 -380,084	-61%	-$26.9M	0.14%	134
2017 Q1	$41.6M	Buy	625,210 +3,871	+0.6%	+$258K	0.34%	64
2016 Q4	$40.6M	Buy	621,339 +110,266	+22%	+$7.15M	0.31%	70
2016 Q3	$36.2M	Sell	511,073 -38,631	-7%	-$2.82M	0.28%	75
2016 Q2	$40.6M	Sell	549,704 -24,626	-4%	-$1.7M	0.31%	67
2016 Q1	$37.3M	Buy	574,330 +209,796	+58%	+$14.3M	0.25%	90
2015 Q4	$28.1M	Sell	364,534 -42,001	-10%	-$3.34M	0.18%	126
2015 Q3	$33.5M	Buy	406,535 +147,303	+57%	+$13.1M	0.21%	113
2015 Q2	$22.8M	Sell	259,232 -33,738	-12%	-$3.1M	0.13%	148
2015 Q1	$25.9M	Sell	292,970 -484,456	-62%	-$43M	0.14%	148
2014 Q4	$64.5M	Sell	777,426 -538,244	-41%	-$44.6M	0.32%	86
2014 Q3	$111M	Sell	1,315,670 -462,280	-26%	-$37.4M	0.5%	56
2014 Q2	$144M	Buy	1,777,950 +244,955	+16%	+$19.3M	0.58%	46
2014 Q1	$117M	Sell	1,532,995 -229,853	-13%	-$16.7M	0.46%	67
2013 Q4	$127M	Sell	1,762,848 -438,954	-20%	-$30.5M	0.48%	59
2013 Q3	$151M	Buy	2,201,802 +31,511	+1%	+$2.08M	0.61%	41
2013 Q2	$138M	Buy	+2,170,291	New	+$141M	0.63%	38

Other funds holding NVS

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Thornburg Investment Management's NVS Position: Q1 2026 in Review

Thornburg Investment Management reduced its Novartis (NVS) stake by 16% in Q1 2026, selling an estimated $119K and leaving 4,114 shares worth $628K. The position accounts for 0.01% of the portfolio, ranked #150.

Thornburg Investment Management first reported a position in NVS in Q2 2013 and has held it in 50 quarters since. The position peaked at $151M in Q3 2013. 1,596 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Thornburg Investment Management held 4,114 shares of Novartis worth $628K as of Q1 2026.
Thornburg Investment Management sold 775 Novartis shares in Q1 2026, an estimated $119K.
Novartis made up 0.01% of Thornburg Investment Management's portfolio in Q1 2026, its #150 holding.
Thornburg Investment Management first reported a position in Novartis in Q2 2013 and has held it in 50 quarters since.
Thornburg Investment Management's Novartis position peaked at $151M in Q3 2013.
1,596 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Thornburg Investment Management's 13F filing for Q1 2026, filed 12 May 2026.